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We report the sequence of toxin IV of Leiurus quinquestriatus quinquestriatus, one of the live toxins lethal 
for the mouse purified from the venom of this scorpion. Automatic sequencing of the S-carboxymethylated 
protein and derived peptides obtained by action of the Staphylococcus aureus protease allowed us to work 
out the complete sequence of 65 residues. The toxin which was found to be blocked at the C-terminal end 
has an extra residue at the N-terminus as compared with other toxins from Asian and African scorpions. 
Moreover, toxin IV must be classified as an a-scorpion toxin since it was shown to displace competitively 
rz51-toxin II of Androctonus australis Hector ( lzsI-AaH II) from its binding site on rat brain synaptosomes. 
Nevertheless, it cannot be classified in one of the groups of scorpion toxins previously defined on the level 
of their antigenic properties. Again the classifications of scorpion toxins based on sequence homologies or 
antigenic properties upport one another. 
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1. INTRODUCTION 
Scorpion toxins isolated from venoms of 
animals collected in North Africa were first 
classified into three groups of toxins according to 
structural homologies [ 1,2]. More recently, due to 
their binding properties to rat brain synaptosomes 
[3] and their action on sodium channels of ex- 
citable membranes, two types of scorpion toxins 
Abbreviations: AaH, Androctonus australis Hector; 
Bot, Buthus occitanus tunetanus; Amm, Androctonus 
mauretanicus mauretanicus; Lqq, Leiurus quin- 
questriatus quinquestriatus; Be, Buthus epeus; CsE, 
Centruroides culpturatus Ewing; Css, Centruroides uf- 
fusus suffusus; Ts, Tityus serrulatus; AaH I, AaH I ’ 
(28) - AaH I’ ’ (29) - AaH II (30) - AaH III (19) - Bot 
I and Bot II (25) - Bot III (31) - Lqq V (11) - Amm V 
(32) - Be Ml0 (33) - CsE I (34) - Css II (5) - Ts VII (22) 
were characterized: a-toxins and P-toxins [4]. cy- 
Toxins and &toxins bind to rat brain synap- 
tosomes on two different sites both related to the 
sodium channel, the former binds in a voltage- 
dependent manner, while the latter binds in- 
dependently of membrane potential. Up to now all 
the toxins purified from the Buthinae collected in 
North Africa and Asia are a-toxins, while those 
purified from the Centrurinae Centruroides suf- 
fusus (Central America) are&toxins [5] and finally 
those purified from Tityinae are either a- or p- 
toxins ([6], unpublished). In the case of Cen- 
truroides sculpturatus (North America) contradic- 
tory results have been published [7-91. 
From the venom of Leiurus quinquestriatus 
quinquestriatus originating from Sudan, 5 toxins 
were isolated [IO]. They present the general 
features of scorpion toxins; i.e., they are low- 
molecular-mass basic proteins cross-linked by 4 
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disulfide bridges. The structure of toxin V, the 
most represented in the venom and the most potent 
(LDso on mice, 0.5 pg), was already determined 
[ll]. It belongs to the same group as toxin II of 
Androctonus australis Hector, the most potent LY- 
scorpion toxin known (L&O on mice, 0.18 yg). We 
report here the primary structure of the least po- 
tent of the L. quinquestriatus quinquestriatus tox- 
ins, i.e. toxin IV (LDso = 1.40 pg). These data are 
part of a structure-activity relationship study on 
scorpion toxins. 
2. MATERIALS AND METHODS 
Toxin IV was purified according to Miranda et 
al. [lo] from a batch of venom provided by F.G. 
Celo (Zweibrucken, FRG). This venom was ob- 
tained from scorpions collected in the area of Kar- 
toum (Sudan). 
Staphylococcus aureus V8 protease (EC 3.4.21) 
was from Miles Laboratories; diisopropylphos- 
phofluoridate carboxypeptidase A (EC 3.4.12.3) 
and carboxypeptidase B (EC 3.4.12.3) from 
Worthington (Freehold, NJ). Biogel P6 was pur- 
chased from Bio-Rad Laboratories (Richmond, 
CA) and Sephadex G-25 from Pharmacia (Upp- 
sala, Sweden). Iodoacetic acid, dithioerythritol, 
Quadrol and dimethylbenzylamine sequanal grade 
from Pierce Chemical Company (Rockford, IL). 
N-Ethylmorpholine (purum grade) was provided 
by Fluka (Switzerland) and hake parvalbumin was 
prepared according to Rochat et al. [12]. 
2.1. Activity tests 
LDso values were established on C57BL/6 mice 
from CSEAL (Orleans-La Source, France) by sub- 
cutaneous or intracerebro-ventricular injections 
[ 131 according to Behrens and Karber [ 141. Com- 
petitive experiments were conducted on rat brain 
synaptosomes using a “‘1 derivative of toxin II of 
A. austrafis Hector (12’1AaH II) and native toxins 
according to Jover et al. [15]. The radioactive tox- 
in was prepared according to [16]. Its specific 
radioactivity was 700 Ci/mmol. 
2.2. Chemical modifications of toxin IV 
After reduction of the protein (20 h at 40°C 
under nitrogen), S-methylation by methyl iodide or 
S-carboxymethylation by iodoacetic acid were per- 
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formed according to Rochat et al. [ 171 and 
Crestfield et al. [ 181, respectively. In both cases 
5 M guanidine-HCl and dithioerythritol were used 
as denaturing and reducing agents [19]. The 
modified protein was dialyzed against water in 
Spectra Por 3 membrane. 
2.3. Automatic sequential degradations 
The N-terminal sequence of the reduced and S- 
carboxymethylated toxin and the peptides derived 
from the action of S. aureus protease were 
established using a SOCOSI PS 100 protein se- 
quencer as in [11,19]. The S-carboxymethylated 
protein (400 nM) was sequenced in the presence of 
1 M Quadrol, as recommended by Edman and 
Begg WI. 
The degradation of the peptides was performed 
with dimethylbenzylamine buffer prescribed by 
Hermodson et al. [21] in the presence of hake par- 
valbumin as protein carrier [12] to avoid losses of 
material. Phenylthiohydantoins amino acids 
(PTHaa) were identified on an HPLC Waters 
System, as described by Bechis et al. [22]. 
2.4. Amino acid analysis 
Protein or peptides were hydrolyzed by 5.7 N 
hydrochloric acid in sealed evacuated tubes at 
110°C for 20 h. The analyses were then achieved 
on a Beckman 12OC amino acid analyzer. 
2.5. Digestion by Staphylococcus aureus protease 
The conditions recommended by Houmard and 
Drapeau [23] for the cleavage of glutamoyl bonds 
were closely followed, i.e., a 0.05 M ammonium 
bicarbonate buffer (pH 7.8) was used, the en- 
zyme : substrate ratio being 10% (w/w). The digest 
was submitted to gel filtration either on Biogel P6 
in an ammonium bicarbonate buffer (0.1 M, pH 
8.5) or on Sephadex G-25 equilibrated in 0.5 M 
acetic acid. 
2.6. Digestions by carboxypeptidases A and B 
S-methylated as well as S-carboxymethylated 
toxin samples (100 nmol) were digested at 37°C in 
an N-ethylmorpholine acetate buffer (0.2 M, pH 
8.0). In the case of carboxypeptidase A, the en- 
zyme:substrate ratio was 5% (w/w), whereas this 
ratio was 10% for digestion by carboxypeptidase 
B. Aliquots were removed at various intervals 5 
15, 60, 90, 180 min for amino acid analyses. 
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3. RESULTS AND DISCUSSION 
When the digest by the S. aureus protease of 1 
pmol S-carboxymethylated toxin IV was filtered on 
Biogel P6, fOUr peptides PI-~, PS-26, P2,-33 and 
P34_54 were obtained in a pure form (fig.1, table 
1). The last fraction, FS, in which no UV ab- 
sorbance was detectable, due to a very large dilu- 
tion (400 ml), was concentrated by lyophilisation 
and further fractionated on a column of Sephadex 
G-25 equilibrated in 0.5 M acetic acid. Thus, pep- 
tide P55_65 was obtained in a pure form (fig.2, 
table 1). This peptide contains two arginine resi- 
dues and several hydrophobic residues which may 
well explain its strong adsorption on Biogel P6: it 
elutes in a volume greater than the total volume of 
the column. PSS-65 is, IIIOSt probably for the above 
reason, the peptide obtained with the lowest yield 
(table 1). 
The sequence of toxin IV presented on fig.3 is 
deduced from the sum of the results obtained by 
automatic Edman degradation runs made on the 
protein and the peptides derived from it. The 
‘Quadrol program’ was used with the reduced and 
S-carboxymethylated toxin (400 nmol). Forty 
residues were so determined without any ambigui- 
ty. The five peptides obtained by S. aureus pro- 
tease digestion were degraded (40-100 nmol each) 
f _P5-26 
_P34-54 
using the peptide program and dimethylben- 
zylamine as coupling buffer. For the C-terminal 
peptide, the automatic sequencing showed an 
arginine residue in the last position. This sequence 
of 65 amino acids is in complete agreement with 
the amino acid composition of the protein. Pep- 
tides Pi-4 and P34-54 were unexpected as they were 
obtained by cleavage of peptide bonds Asp4--Ala5 
and Asp54-Lysss although conditions that were 
described to specifically split glutamoyl bonds [23] 
were used. After action of carboxypeptidase A on 
the S-carboxymethylated toxin (100 nmol) no free 
amino acid could be detected which is due to the 
enzyme specificity. However, the same result was 
obtained when the digestion by carboxypeptidase 
B was done either on the S-carboxymethylated or 
on the S-methylated erivatives of toxin IV. Thus, 
the C-terminal end of this protein is not free: it is 
blocked most probably by amidation of the cy- 
carboxylate of the C-terminal arginine residue. In- 
deed, many scorpion toxins have been shown to 
have their C-terminal end blocked by amidation: it 
is the case for A. australis Hector toxin II [24], L. 
quinquestriatus quinquestriatus toxin V [ 111, 
Buthus occitanus tunetanus toxins I and II [25] and 
Tityus serrulatus toxin VII [22]. 
Considering the classification based on struc- 
tural homologies (fig.4) obtained when half- 
: ; 
;P27-33 
: ’ I-. 
F5 
Fig. 1. Gel filtration on Biogel P6 of peptides obtained by action of Stuphy/ococcus aureus V8 protease. Two columns 
in series (2 x 200 cm) equilibrated in 0.1 M ammonium bicarbonate (pH 8.5). Full line absorbance at 280 nM; dotted 
line, absorbance at 230 nm; flow rate, 10 ml/h. 
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Table 1 
Amino acid composition of peptides obtained by action of Staphylococcus protease on S-carboxymethylated toxin IV 
Amino acids S-Carboxymethylated Peptide Peptide Peptide Peptide Peptide 
protein l-4 5-26 21-33 34-54 55-65 
Carboxymethylcysteine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Vaiine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
7.5 (8) 
8.9 (9) 
2.9 (3) 
2.7 (3) 
3.0 (3) 
3.0 (3) 
7.0 (7) 
4.0 (4) 
2.8 (3) 
0 
3.7 (4) 
2.0 (2) 
4.5 (5) 
0 
0 
6.0 (6) 
3.3 (3) 
1.8a (2) 
2.6 (3) 1.2 (1) 2.6 (3) 0.4 (1) 
1.0 (1) 4.9 (5) 0.8 (1) 2.2 (2) 
1.9 (2) 1.0 (1) 
2.0 (21 1.0 (1) 
1.2 (1) 1.1 (1) 1.1 (1) 
0.9 (1) 2.1 (2) 
1.1 (1) 1.5 (1) 1.3 (1) 3.0 (3) 1.0 (1) 
2.2 (2) I.1 (1) 1.3 (1) 
0.9 (1) 1.1 (I) 1.0 (1) 
0.9 (1) 0.8 (1) 1.8 (2) 
1.5 (2) 
2.9 (3) 1.3 (2) 
1.0 (I) 0.9 (I) 1.9 (2) 1.6 (2) 
1.0 (1) 2.1 (2) 
2.0a (2) 
Number of residues 65 4 22 7 21 11 
Yield of purification 43% 42% 
a Spectrophotometric determination 
50% 28% 20% 
cystine residues are aligned [2], it clearly appears 
that toxin IV has an extra residue at the N- 
terminus, which makes it different from other 
scorpion toxins. However, one can observe some 
homologies with toxins of group II: except the 
glycine 1 and alanine 5, there is a great homology 
with Be Ml0 for the ten first residues. The se- 
quence 12-15 (NCVY) is found in groups I and 
Fig.2. Gel filtration on Sephadex G-25 of fraction PI_4 obtained by Biogel P6 filtration. The column (1 x 150 cm) is 
equilibrated in 0.5 M acetic acid. Flow rate, 5 ml/h. 
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P 5-26 
->->->->->->->->-,-,-)-)-)-)-)-)-)_) 
AYIADDKNCVTTCCSNSYCNTE 
P 27-33 
->->->->->->-> 
CTKNCAE 
P 34-54 
->-,->->_)-,-,-,-,-)-)-)-)-)-)-)-)-)-)-)-> 
SGYCQYLGKYGNACYCIRLPD 
P 55-65 
-,->-,-b&>->-b>->-> 
KVPIAIPCKCR 
Fig.3. Amino acid sequence of the toxin IV of Leiurus quinquestriutus quinquestriatus. Positions determined by 
automatic sequencing. Vertical arrows indicate splitting by Stuphylococcus aureus protease. The IUPAC one-letter 
notation for amino acid sequences is used [(1968) Eur. J. Biochem. 5, 151-1531. 
AaH I 
AaH I' 
' AaH I" 
Aali III 
1 10 20 30 40 50 60 70 
KRDCYIVYPN-NCVYHCVP--P---CDGLCKKN-GGSSGS-CSFLVPSGLACWC-KDLP-DNVPIKDT--SRKCT- 
KRDGYIVYPN-NCVYHCIP--P---CDGLCKKN-GGSSGS-CSFLVPSGLACUC-KDLP-DNVPIKDT--SRKCT- 
KRDGYIVYPN-NCVYHCVP--P---CDGLCKKN-GGSSGS-CSFLVPSGLACWC-KDLP-DNVPIKDT--SRKCTR 
VRDCYIVNSK-NCVYHCVP--P---CDGLCKKN-GAKSCS-CGFLIPSGLACWCV-AL~-DNVPIKDP--SYKCHS 
AaH Ii 
ROT III 
II Lqq V 
Amm V 
Be Ml0 
IV Lqq IV 
VKDCYIVDDV-NCTYFCCR---NAYCNEECTKL-KGESC-YCQWASPYGNACYCYK-LP-DHVRTKGP---GRCH- 
VKDGYIVDDR-NCTYFCGR ---NAYCNEECNKL-KGESC-YCQWASPYGNACYCYK-VP-DHVRTKGP---GRCN- 
LKDCYIVDDK-NCTFFCGR---NAYCNDECKKK-GGESG-YCQWASPYGNACWCYK-LP-DRVSIKEK---GRCN- 
LKDGYIIDDL-NCTFFCGR---NAYCDDECKKK-GGESG-YCQWASPYGNACWCYK-LP-DRVSIKEK---GRCN- 
VRDGYIADDK-DCAYFCGR ---NAYCDEECKKC-GAESG-KCWYAGQYGNACWCYK-LP-DWVPIKQKV-SGKCN- 
GVRDAYIADDK-NCVYTCCS---NSYCNTECTKN-GAESG-YCQWLGKYGNACWCIK-LP-DKVPIRIP---GKC-R 
BoT I CRDAYIAQPE-NCVYECAQ---NSYCNDLCTKN-GATSG-YCQWLGKYGNACWC-KDLP-DNVPIRIP---GKCHF 
Ill 9oT I I CRDAYIAQPE-NCVYECAK---NSYCNDLCTKN-GAKSG-YCQWLGRWGNACXCI-DLP-DKVPIRIE---GKCHF 
css II 
V CsE I 
TS VII 
-KEGYLVSKSTGCKYECLKLGDNDYCLRECKQQYGKSSGGYCYAF-----ACWC-THLY-EQAVVWPLPNKT-CN- 
-KDGYLVEK-TCCKKTCYKLGENDFCNRECKWKHIGGSYGYCYGF-----GCYC-EGLP-DSTQTWPLPNK--CT- 
-KECYLMDHE-CCKLSCF-IRPSGYCGRECGIKKG-SSG-YC-AW-P---ACYCY-GLP-NWVKVWDR-ATNKC-- 
Fig.4. Amino acid sequences of scorpion toxins classified according to their structural homologies. 
III, while phenylalanine or glutamic acid in posi- 
tion 15 is replaced by a threonine residue in Lqq 
IV. The presence of glutamic acid in positions 30 
and 37 is a characteristic feature of group II, 
whereas the sequence 33-37 (KNGA) is in com- 
mon in the groups I and III. The region 42-62 of 
Bot I (group III) is very close to the corresponding 
region of Lqq IV, except that it does not show the 
deletion in position 58 as observed in toxins of 
group II and for Lqq IV. Lastly, the C-terminal 
region of Lqq IV more closely resembles the C- 
terminal region of group III toxins. These observa- 
tions are summarized by the systematic lassifica- 
tion proposed by Dufton and Rochat [26] on the 
basis of amino acid compositions as well as se- 
quence comparisons, which suggests the evolu- 
tionary history of the family of scorpion toxins. 
This work confirms the above-mentioned 
homologies since Lqq IV differs from Bot I and 
Bot II (group III) only by 16 and 10 amino acids, 
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respectively, and from BeM 10 (group II) by 18 
amino acids, the resemblance being even more evi- 
dent when comparing the sequences. The alternate 
homologies with toxins of one or another group 
may explain that Lqq IV toxin cannot be classified 
in the already known groups of scorpion toxins. 
This is confirmed by immunological tests of im- 
munodiffusion since scorpion toxins have been 
classified according to their antigenic properties 
[27]. When Lqq IV was tested by immunodiffusion 
with antisera prepared against toxin belonging to 
group I, II and III, no cross reactions could be 
observed ([27], P. Dolori, personal communica- 
tion). In the same way, no cross reaction was 
observed when Lqq IV antisera were used against 
toxins of other groups. 
As for other scorpion toxins, the toxicity of Lqq 
IV for the mouse was dependent on the mode of in- 
jection. The ratio between the values of L& ob- 
tained by subcutaneous and intracerebroven- 
tricular injections depends on the toxin affinities 
for its receptor present in the periphery and in the 
central nervous systems. In the case of Lqq IV the 
ratio is 52 (1400 ng SC/27 ng ICV) a value close to 
values found for Bot I and Bot II from group III 
(Martin, M.F., personal communication). Lqq V 
from the same venom shows a ratio of 200 (500 ng 
SU2.5 ng ICV) a higher value closer to the ratio 
of AaH II (250 ng SC/O.5 ng ICV), both toxins 
belonging to the same group II. 
Finally, in fig.5, are represented the results ob- 
tained when ‘251-AaH II was tentatively displaced 
by AaH II and Lqq IV: it is obvious that both tox- 
ins are able to fully displace the labelled a-toxin 
AaH II from its binding site on rat brain synap- 
tosomes. The calculated Ko.5 values (i.e., the con- 
centrations of native toxins which displace 50% of 
the labelled toxin) are, respectively, 3.3 x lo-” M 
for AaH II and 3 x lO-8 M for Lqq IV. The value 
found for AaH II is in good accordance with the 
values previously found for this toxin [15]. One 
can calculate the ratio between the KO 5 values 
(= 90) and the ratio between the LDSO (= 57) of 
the two toxins: two close numbers that show a 
good correlation between the lethal activity of this 
molecule and its ability to interact with the sodium 
channel of rat brain synaptosomes. This is in 
favour of the same mode of action for AaH II and 
Lqq IV. Thus, Lqq IV must be considered as an CY- 
scorpion toxin. However, it cannot be classified on 
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Fig.5. Displacement of ‘ZS1-AaH II (700 Ci/mmol) by 
native AaH II (0) and Lqq IV (x ). Synaptosomal PI 
fraction (0.3 mg protein per ml, i.e., a binding sites 
concentration of 10-r’ M) was incubated 30 min at 37°C 
in the presence of 0.2 nM “‘1-AaH II and various 
amounts of AaH II or Lqq IV. B, is the binding of ‘251- 
AaH II in the absence of native toxin and B the binding 
in the presence of the indicated concentrations of native 
toxin. The non-specific binding (22% of the total 
binding) has been subtracted. 
the level of its sequence and its immunological pro- 
perties within the a-toxin groups previously 
described: it represents the first a-scorpion toxin 
of group IV [35]. 
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